The report "Biologics Safety Testing Market by Product & Service (Consumables, Instrument, Services), Application (Vaccine, Monoclonal Antibodies, Blood products, Cell & Gene Therapy Products), Test Type (Endotoxin, Myoplasm, Sterility Test) - Global Forecast to 2026" The global biologics safety testing market is projected to reach USD 6.2 billion by 2026 from USD 3.4 billion in 2021, at a CAGR of 12.4% during the forecast period.

The growth of the global biologics safety testing market is driven by factors such as the growth in the biologics and biosimilars markets, growing concerns over cell culture contamination, and rising biopharmaceuticals R&D activities and investments.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=34624144

The residual host-cell proteins and DNA detection tests segment accounted for the largest share of the Biologics Safety Testing market

Based on test type, the biologics safety testing market is segmented into residual host-cell proteins and DNA detection tests, endotoxin tests, sterility tests, mycoplasma tests, bioburden tests, and virus safety tests. the residual host-cell proteins and DNA detection tests segment accounted for the largest market share.

The monoclonal antibodies manufacturing segment accounted for the largest market share of the Biologics safety testing market

Based on application, the biologics safety testing market is segmented into monoclonal antibodies manufacturing, vaccines manufacturing, blood and blood products manufacturing, cellular and gene therapy products manufacturing, and other applications. the monoclonal antibodies manufacturing segment accounted for the largest market share.

The Asia Pacific region is the fastest growing region of the Biologics safety testing market.

The Asia Pacific market is projected to witness the highest growth rate during the forecast period, primarily due to the expansion of key market players in emerging Asia Pacific countries, increasing expenditure on life science research, and the increasing trend of pharmaceutical outsourcing to Asia Pacific countries.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=34624144

Key Market Players

Prominent players in the biologics safety testing market are Charles River Laboratories, Inc. (US), Lonza (Switzerland), Thermo Fisher Scientific, Inc. (US), Merck KGaA (Germany), SGS SA (Switzerland), WuXi AppTec (China), and Eurofins Scientific (Luxembourg). The key players in this market are focusing on strategic expansions, partnerships, and product launches and approvals to expand their presence in the market.

The study categorizes the biologics safety testing market into the following segments and subsegments:

Biologics Safety Testing Market, by Product & Services

Consumables
Instrument
Services
Biologics Safety Testing Market, by Application

Vaccine Manufacturing
Monoclonal Antibodies Manufacturing
Cellular & Gene Therapy Products Manufacturing
Blood and Blood Products Manufacturing
Other Application
Biologics Safety Testing Market, by Test Type

Endotoxin Test
Sterility Test
Mycoplasma Tests
Bioburden Tests
Residual Host-cell Proteins & DNA Detection Tests
Virus safety Test
Biologics Safety Testing Market, by Region

North America
Europe
Asia Pacific
Latin America
The Middle East and Africa
Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=34624144

Don’t miss out on business opportunities in Biologics Safety Testing Market. Speak to our analyst and gain crucial industry insighs that will help your businessgrow.

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:

Mr. Aashish Mehra

MarketsandMarkets™ INC.

630 Dundee Road

Suite 430

Northbrook, IL 60062

USA : 1-888-600-6441

[email protected]